Australian e-learning platform Matific enters India

Matific is an online maths resource for kids from primary to Grade 6. This solution will be available at a monthly fee of Rs 210 in the Indian market.

Moneycontrol News

April 15, 2020 / 18:36 IST

Australian e-learning platform Matific, an online maths resource for kids from primary to Grade 6, has entered the Indian education technology market. This solution will be available at a monthly fee of Rs 210 in the Indian market.

The company said in a statement that the solution has been designed by mathematics professors and curriculum experts for parents looking for engaging solutions that are aligned to their child’s school curriculums.

Called Matific Galaxy, this solution features hundreds of maths activities aligned with school curriculums of ICSE and CBSE boards. Matific’s home product aims to provide a solution to conventional home-schooling and ensure that kids are well prepared for the future until the lockdown period ends.

Matific said that its content has been proven to help improve students' math results by 34 percent. The programme provides parents with access to a dashboard where they can keep track of their child’s mathematics achievements and progress.

“Given the current environment, schools institutions are going online around the world as they send students home with no timeline for return. Matific’s solutions enable students to continue their learning process. We want to ensure that all students in all areas of India have the opportunity to continue learning during this time. This means ensuring that the price is not an issue.” said Vibha Mahajan, VP, Matific India.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show

Australian e-learning platform Matific enters India

Matific is an online maths resource for kids from primary to Grade 6. This solution will be available at a monthly fee of Rs 210 in the Indian market.

Related stories

Trending news